Inactive Instrument

Other languages AVAX Technologies, Inc. Other OTC

Equities

Avax Technologies Announces Results of its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial in Patients with Relapsed Stage III or IV Ovarian Cancer	27/16/27
AVAX Technologies : Announces the Appointment of Chief Executive Officer	19/15/19
AVAX Technologies, Inc. Appoints Adele Sommerfeld as Chief Executive Officer	19/15/19
AVAX Technologies Inc. announced that it expects to receive $45 million in funding	04/15/04
AVAX Technologies Inc. Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine Ovax	11/14/11
AVAX TEC : AVAX Technologies, Inc. Closes Bridge Financing	17/09/17
AVAX TECHNOLOGIES : AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing	31/08/31

No results for this search